Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities.

Høgh P, Garde E, Mortensen EL, Jørgensen OS, Krabbe K, Waldemar G.

Acta Neurol Scand. 2007 Apr;115(4):248-53.

PMID:
17376122
2.

Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.

Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, Morris CM, O'Brien JT.

Arch Neurol. 1999 Aug;56(8):961-5.

PMID:
10448801
3.

Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms.

Taylor WD, Macfall JR, Payne ME, McQuoid DR, Steffens DC, Provenzale JM, Krishnan KR.

Psychol Med. 2007 Dec;37(12):1763-73. Epub 2007 Mar 5.

PMID:
17335636
4.

Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.

Son SJ, Lee KS, Lee Y, Baek JH, Choi SH, Na DL, Seo SW, Oh BH, Hong CH.

J Clin Psychiatry. 2012 Dec;73(12):1555-62. doi: 10.4088/JCP.12m07702. Epub 2012 Oct 30.

PMID:
23146133
5.

Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort.

Dufouil C, de Kersaint-Gilly A, Besançon V, Levy C, Auffray E, Brunnereau L, Alpérovitch A, Tzourio C.

Neurology. 2001 Apr 10;56(7):921-6.

PMID:
11294930
6.

Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study.

Steffens DC, Potter GG, McQuoid DR, MacFall JR, Payne ME, Burke JR, Plassman BL, Welsh-Bohmer KA.

Am J Geriatr Psychiatry. 2007 Oct;15(10):839-49. Epub 2007 Jul 10.

PMID:
17623814
7.

Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.

Knopman DS, Mosley TH, Catellier DJ, Coker LH; Atherosclerosis Risk in Communities Study Brain MRI Study.

Alzheimers Dement. 2009 May;5(3):207-14. doi: 10.1016/j.jalz.2009.01.027. Epub 2009 Apr 11.

PMID:
19362884
8.

Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.

Smith EE, Egorova S, Blacker D, Killiany RJ, Muzikansky A, Dickerson BC, Tanzi RE, Albert MS, Greenberg SM, Guttmann CR.

Arch Neurol. 2008 Jan;65(1):94-100. doi: 10.1001/archneurol.2007.23.

PMID:
18195145
9.

Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.

Filippini N, Rao A, Wetten S, Gibson RA, Borrie M, Guzman D, Kertesz A, Loy-English I, Williams J, Nichols T, Whitcher B, Matthews PM.

Neuroimage. 2009 Feb 1;44(3):724-8. doi: 10.1016/j.neuroimage.2008.10.003. Epub 2008 Nov 1.

PMID:
19013250
10.

APOE ε4 allele status in korean dementia patients with severe white matter hyperintensities.

Hong YJ, Yoon B, Shim YS, Cho AH, Shin HE, Kim YI, Kim SY, Yang DW.

J Alzheimers Dis. 2011;24(3):519-24. doi: 10.3233/JAD-2011-101611.

PMID:
21297273
11.

The association between delirium and the apolipoprotein E epsilon4 allele in the elderly.

van Munster BC, Korevaar JC, de Rooij SE, Levi M, Zwinderman AH.

Psychiatr Genet. 2007 Oct;17(5):261-6.

PMID:
17728664
12.

Association between ApoE epsilon4 and cognitive impairment after stroke.

Wagle J, Farner L, Flekkøy K, Wyller TB, Sandvik L, Eiklid KL, Fure B, Stensrød B, Engedal K.

Dement Geriatr Cogn Disord. 2009;27(6):525-33. doi: 10.1159/000223230. Epub 2009 Jun 4.

PMID:
19494491
13.

Regional atrophy of transcallosal prefrontal connections in cognitively normal APOE epsilon4 carriers.

Filippini N, Zarei M, Beckmann CF, Galluzzi S, Borsci G, Testa C, Bonetti M, Beltramello A, Ghidoni R, Benussi L, Binetti G, Frisoni GB.

J Magn Reson Imaging. 2009 May;29(5):1021-6. doi: 10.1002/jmri.21757.

PMID:
19388128
14.

Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.

Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH.

Pharmacogenet Genomics. 2008 Apr;18(4):289-98. doi: 10.1097/FPC.0b013e3282f63f29.

PMID:
18334913
15.

Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.

Villalpando-Berumen JM, Mejia-Arango S, Aguilar-Salinas CA, Ordonez-Sanchez ML, Gutierrez-Robledo LM.

J Am Geriatr Soc. 2008 Apr;56(4):677-82. doi: 10.1111/j.1532-5415.2007.01606.x. Epub 2008 Jan 16.

PMID:
18205760
16.

Apolipoprotein E epsilon 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study.

Hämäläinen A, Grau-Olivares M, Tervo S, Niskanen E, Pennanen C, Huuskonen J, Kivipelto M, Hänninen T, Tapiola M, Vanhanen M, Hallikainen M, Helkala EL, Nissinen A, Vanninen RL, Soininen H.

Neurodegener Dis. 2008;5(3-4):186-9. doi: 10.1159/000113698. Epub 2008 Mar 6.

PMID:
18322386
17.

Increased risk of death in community-dwelling older people with white matter hyperintensities on MRI.

Kerber KA, Whitman GT, Brown DL, Baloh RW.

J Neurol Sci. 2006 Dec 1;250(1-2):33-8. Epub 2006 Aug 4.

PMID:
16889799
18.

Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.

van der Walt A, Stankovich J, Bahlo M, Taylor BV, van der Mei IA, Foote SJ, Kilpatrick TJ, Rubio JP, Butzkueven H.

Neurology. 2009 Sep 29;73(13):1018-25. doi: 10.1212/WNL.0b013e3181b9c85e.

PMID:
19786693
19.

Homocysteine and cognitive performance: modification by the ApoE genotype.

Elias MF, Robbins MA, Budge MM, Elias PK, Dore GA, Brennan SL, Johnston C, Nagy Z.

Neurosci Lett. 2008 Jan 3;430(1):64-9. Epub 2007 Oct 30.

PMID:
18023533
20.

VITA study: white matter hyperintensities of vascular and degenerative origin in the elderly.

Fischer P, Krampla W, Mostafaie N, Zehetmayer S, Rainer M, Jungwirth S, Huber K, Bauer K, Hruby W, Riederer P, Tragl KH.

J Neural Transm Suppl. 2007;(72):181-8.

PMID:
17982893

Supplemental Content

Support Center